Hosted on MSN11mon
Bionomics to advance non-SSRI PTSD candidate to Phase III
Bionomics has announced plans to meet with the US Food & Drug Administration (FDA) in Q2 2024 following the release of positive topline data from a Phase IIb trial of its lead candidate BNC210 to ...
manilatimes3mon
Bionomics Publishes the Positive Results from the Phase 2 ATTUNE Study of BNC210 in Patients with Post-Traumatic Stress Disorder in NEJM Evidence
Dec. 09, 2024 (GLOBE NEWSWIRE) -- Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, first-in-class, allosteric ion channel modulators to ...
JSTOR Daily5mon
Bionomics of the Bromeliad-Inhabiting Mosquito Wyeomyia vanduzeei and Its Nursery Plant Tillandsia utriculata
The Florida Entomologist, Vol. 64, No. 4 (Dec., 1981), pp. 491-506 (16 pages) Aquatic stages of the mosquito Wyeomyia vanduzeei Dyar & Knab inhabit leaf axils of the epiphytic bromeliad Tillandsia ...
Nature12d
Observations on the Bionomics of the Marine Nematode, Metoncholaimus SP.
Wieser, W., and Hopper, B. E., Bull. Mus. Comp. Zool. (in the press). Meyers, S. P., and Hopper, B. E., Bull. Mar. Sci., 16 (1966) (in the press).